Your browser doesn't support javascript.
loading
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs.
Hayakawa, Yoshihiro; Kawada, Manabu; Nishikawa, Hiroyoshi; Ochiya, Takahiro; Saya, Hideyuki; Seimiya, Hiroyuki; Yao, Ryoji; Hayashi, Masahiro; Kai, Chieko; Matsuda, Akira; Naoe, Tomoki; Ohtsu, Atsushi; Okazaki, Taku; Saji, Hideo; Sata, Masataka; Sugimura, Haruhiko; Sugiyama, Yuichi; Toi, Masakazu; Irimura, Tatsuro.
Afiliación
  • Hayakawa Y; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Kawada M; Division of Pathogenic Biochemistry, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
  • Nishikawa H; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Ochiya T; Institute of Microbial Chemistry, Microbial Chemistry Research Foundation, Numazu-shi, Japan.
  • Saya H; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Seimiya H; Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Yao R; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Hayashi M; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
  • Kai C; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Matsuda A; Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan.
  • Naoe T; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Ohtsu A; Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Okazaki T; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Saji H; Division of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sata M; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Sugimura H; Department of Pharmacy, Toranomon Hospital, Tokyo, Japan.
  • Sugiyama Y; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Toi M; Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Irimura T; Subcommittee on Non-clinical Studies, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Cancer Sci ; 107(2): 189-202, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26919617
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Modelos Animales de Enfermedad / Descubrimiento de Drogas / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Sci Año: 2016 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Modelos Animales de Enfermedad / Descubrimiento de Drogas / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Sci Año: 2016 Tipo del documento: Article País de afiliación: Japón